Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Tarceva (erlotinib) in patients with advanced non-small cell lung cancer who have not received chemotherapy, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19